Changzhou Qianhong Biopharma CO.,LTD EBIT Margin for the year ending December 31, 2024: 26.03%

Changzhou Qianhong Biopharma CO.,LTD EBIT Margin is 26.03% for the year ending December 31, 2024, a 124.95% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Changzhou Qianhong Biopharma CO.,LTD EBIT Margin for the year ending December 31, 2023 was 11.57%, a -28.80% change year over year.
  • Changzhou Qianhong Biopharma CO.,LTD EBIT Margin for the year ending December 31, 2022 was 16.25%, a 40.32% change year over year.
  • Changzhou Qianhong Biopharma CO.,LTD EBIT Margin for the year ending December 31, 2021 was 11.58%, a -229.62% change year over year.
  • Changzhou Qianhong Biopharma CO.,LTD EBIT Margin for the year ending December 31, 2020 was -8.93%, a -150.11% change year over year.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin